ABMC — American Bio Medica Balance Sheet
0.000.00%
FinancialsHighly SpeculativeMicro Cap
- $0.00m
- $0.11m
- $0.91m
Annual balance sheet for American Bio Medica, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.113 | 0.004 | 0.098 | 0.115 | 0.034 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.452 | 0.37 | 0.407 | 0.723 | 0.284 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1.61 | 1.22 | 1.18 | 1.34 | 0.769 |
Net Property, Plant And Equipment | 0.718 | 0.717 | 0.617 | 0.522 | 0.479 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 2.48 | 2.08 | 1.93 | 1.88 | 1.27 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Current Liabilities | 1.82 | 1.69 | 2.02 | 2.82 | 3.6 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.62 | 2.87 | 3.18 | 2.83 | 3.61 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.146 | -0.79 | -1.26 | -0.944 | -2.34 |
Total Liabilities & Shareholders' Equity | 2.48 | 2.08 | 1.93 | 1.88 | 1.27 |
Total Common Shares Outstanding |